Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SAM ACTION, INC. via SAM ACTION, INC.
2026 · third_quarter · Q3
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Source: Senate LDA
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
No Deductions for Marijuana Businesses Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbied to attempt to prevent passage of the CURE Act (H.R. 5040) in the House Oversight Committee.
Lobbied to assist in the drafting and garnering support for the STOP Pot Act (H.R. 5323).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
SAFE Banking Act (H.R. 1996, S. 910).
Marijuana Opportunity Reinvestment and Expungement Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
Medical Marijuana and Cannabidiol Research Expansion Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Medical Marijuana and Cannabidiol Research Expansion Act (S. 253, H.R. 8454).
Protecting Kids from Candy-Flavored Drugs Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
Cannabidiol and Marihuana Research Expansion Act
Client: SAM ACTION, INC. · Firm: SAM ACTION, INC.
Medical Marijuana and Cannabidiol Research Expansion Act (S. 253, H.R. 8454).
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
SAFE Banking Act (H.R. 1996, S. 910).
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Advocating against CCP-operating marijuana farms.
Advocating for a prohibition on hemp-derived intoxicants and advocating for restrictions on prediction markets.
Advocating for a federal ban on kratom.
Opposing the SAFE Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAM ACTION, INC. via SAM ACTION, INC.
2026 · second_quarter · Q2
Advocating for a prohibition on hemp-derived intoxicants and advocating for restrictions on prediction markets.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Advocating against CCP-operating marijuana farms.
Opposing the SAFE Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAM ACTION, INC. via SAM ACTION, INC.
2026 · first_quarter · Q1
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Advocating for a prohibition on hemp-derived intoxicants and advocating for restrictions on prediction markets.
Advocating against CCP-operating marijuana farms.
Opposing the SAFE Banking Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAM ACTION, INC. via SAM ACTION, INC.
2025 · fourth_quarter · Q4
Opposing the SAFE Banking Act.
Advocating for a prohibition on hemp-derived intoxicants.
Advocating against CCP-operating marijuana farms.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAM ACTION, INC. via SAM ACTION, INC.
2025 · third_quarter · Q3
Opposing the SAFE Banking Act.
Advocating for a prohibition on hemp-derived intoxicants.
Advocating against CCP-operating marijuana farms.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAM ACTION, INC. via SAM ACTION, INC.
2025 · second_quarter · Q2
Opposing the SAFE Banking Act.
Advocating for a prohibition on hemp-derived intoxicants.
Advocating against CCP-operating marijuana farms.
SAM ACTION, INC. via SAM ACTION, INC.
2025 · first_quarter · Q1
Opposing the SAFE Banking Act.
Advocating for the "Miller Amendment" (prohibition on hemp-derived intoxicants).
Advocating against CCP-operating marijuana farms.
SAM ACTION, INC. via SAM ACTION, INC.
2024 · fourth_quarter · Q4
Lobbying related to addressing the issue of illicit marijuana grows operated in the United States but run by foreign entities.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
SAM ACTION, INC. via SAM ACTION, INC.
2024 · third_quarter · Q3
Lobbying related to addressing the issue of illicit marijuana grows operated in the United States but run by foreign entities.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
SAM ACTION, INC. via SAM ACTION, INC.
2024 · second_quarter · Q2
Lobbying related to addressing the issue of illicit marijuana grows operated in the United States but run by foreign entities.
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill and Agriculture Appropriations bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS). Lobbying also pertained to defeating an NDAA provision banning marijuana testing for military recruits.
SAM ACTION, INC. via SAM ACTION, INC.
2024 · first_quarter · Q1
Lobbying related to addressing the issue of illicit marijuana grows operated in the United States but run by foreign entities.
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAM ACTION, INC. via SAM ACTION, INC.
2023 · fourth_quarter · Q4
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbying related to addressing the issue of illicit marijuana grows operated in the United States but run by foreign entities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAM ACTION, INC. via SAM ACTION, INC.
2023 · third_quarter · Q3
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbied to attempt to prevent passage of the CURE Act (H.R. 5040) in the House Oversight Committee.
Lobbied to assist in the drafting and garnering support for the STOP Pot Act (H.R. 5323).
SAM ACTION, INC. via SAM ACTION, INC.
2023 · second_quarter · Q2
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAM ACTION, INC. via SAM ACTION, INC.
2023 · second_quarter · Q2
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAM ACTION, INC. via SAM ACTION, INC.
2023 · first_quarter · Q1
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891).
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAM ACTION, INC. via SAM ACTION, INC.
2022 · fourth_quarter · Q4
MORE Act (H.R. 3617), Cannabis Administration and Opportunity Act (S. 4591), Protecting Kids from Candy-Flavored Drugs Act (H.R. 8839), Combating Violent and Dangerous Crime Act (S. 4628), States Reform Act (H.R. 5977).
Medical Marijuana and Cannabidiol Research Expansion Act (S. 253, H.R. 8454).
SAFE Banking Act (H.R. 1996, S. 910).
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), preventing the advocation of illegal drug use in anti-impaired driving advertisements, encouraging federal action against false therapeutic claims made about marijuana, and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Lobbying activities related to appropriations items including blocking marijuana rescheduling (CJS), creating an exception to the Rohrabacher-Farr Amendment to allow the Department of Justice to enforce USC 860 (CJS), getting an investigation of the HHS marijuana rescheduling review (Ag/FDA and LHHS), recommending more research on high-potency marijuana (Ag/FDA and LHHS), and prohibiting hemp intoxicants in in the Agriculture Appropriations bill.
Lobbying related to support for the No Deductions for Marijuana Businesses Act (S.471/H.R.1447)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Lobbying activities relate to updating tax requirements for trafficking of illicit substances.
Lobbying activities related to supporting the addition of an amendment to the Farm Bill and Agriculture Appropriations bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Lobbying activities related to supporting the addition of an amendment to the 2023 Farm Bill and Agriculture Appropriations bill to federally ban the sale of synthetic and psychoactive hemp-derived compounds such as Delta-8 THC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Lobbying activities related to opposing the advancement and passage of the SAFE Banking Act (S.1323, H.R.2891) and SAFER Banking Act (S. 2860).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Appropriations amendment related to federal funding for studying marijuanas impact on mental health.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE